About CAPNIA

CAPNIA is a private company developing novel therapeutic products using its proprietary medical gas delivery system.  We are targeting a number of chronic diseases treatable with topical application of well understood, safe and effective gas compounds.  Our first product is finishing Phase IIb clinical trials for the treatment of acute migraines and related symptoms.  28 million Americans and over 240 million people worldwide suffer from this debilitating condition.

CAPNIA is funded by Vivo Ventures, Asset Management Company, Teknoinvest Management AS, Alliance Venture and Novel Bioventures. We are located in Palo Alto, California.